DDAH2 and type 2 diabetes mellitus: CAPG and DDAH2, as key node genes, not only serve as early diagnostic biomarkers but also possibly influence diseases by the immune-metabolism pathway, proving a theoretical foundation for the development of stem cell-based combination therapies in T2DM and sepsis.